Are you a clinical specialist involved in the diagnosis and management of patients with suspected dementia?
Are you a clinical specialist involved in the diagnosis and management of patients with suspected dementia?
Photo: Designed by Freepik
Published 6 March 2025
Share this article
PREDICTOM is inviting clinical specialists (aka secondary and tertiary care physicians) to complete this short survey. We want to hear about your current clinical practice when managing patients who you suspect have dementia. We also ask some questions about Alzheimer’s disease and mild cognitive impairment.
Your responses will help us develop recommendations for optimising clinical practice guidelines, considering new technologies to support diagnosis and facilitators and barriers to implementation.
The PREDICTOM is pleased to announce the launch of Level 2 of its international clinical study—an important next step made possible entirely through the generosity, time, and commitment of participants across Europe. The participants' contributions continue to drive forward our shared goal: improving the early detection of Alzheimer’s disease through accessible, reliable, and science-driven tools.
A single drop of blood may soon help identify Alzheimer’s disease - even before symptoms appear. Researchers from the PREDICTOM study are exploring a simple, cost-effective finger-prick test that measures a breakthrough biomarker called p-Tau217, offering hope for earlier and more accessible screening. The finger-prick test is included in PREDICTOM Level 1 clinical study.
